- Home
- RHLD vs CADL Comparison
RHLD vs CADL Comparison
Compare RHLD & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RHLD
- CADL
- Stock Information
- Founded
- RHLD 2024
- CADL 1999
- Country
- RHLD United States
- CADL United States
- Employees
- RHLD N/A
- CADL N/A
- Industry
- RHLD
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- RHLD
- CADL Health Care
- Exchange
- RHLD NYSE
- CADL Nasdaq
- Market Cap
- RHLD 217.1M
- CADL 234.8M
- IPO Year
- RHLD N/A
- CADL 2021
- Fundamental
- Price
- RHLD $28.96
- CADL $4.81
- Analyst Decision
- RHLD
- CADL Strong Buy
- Analyst Count
- RHLD 0
- CADL 4
- Target Price
- RHLD N/A
- CADL $21.00
- AVG Volume (30 Days)
- RHLD 68.4K
- CADL 854.0K
- Earning Date
- RHLD 05-23-2025
- CADL 05-20-2025
- Dividend Yield
- RHLD N/A
- CADL N/A
- EPS Growth
- RHLD N/A
- CADL N/A
- EPS
- RHLD 12.93
- CADL N/A
- Revenue
- RHLD $420,571,000.00
- CADL N/A
- Revenue This Year
- RHLD N/A
- CADL N/A
- Revenue Next Year
- RHLD N/A
- CADL N/A
- P/E Ratio
- RHLD $2.24
- CADL N/A
- Revenue Growth
- RHLD 7.67
- CADL N/A
- 52 Week Low
- RHLD $24.22
- CADL $3.79
- 52 Week High
- RHLD $69.99
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- RHLD N/A
- CADL 42.39
- Support Level
- RHLD N/A
- CADL $4.34
- Resistance Level
- RHLD N/A
- CADL $5.34
- Average True Range (ATR)
- RHLD 0.00
- CADL 0.33
- MACD
- RHLD 0.00
- CADL 0.10
- Stochastic Oscillator
- RHLD 0.00
- CADL 47.11
About RHLD RESOLUTE HOLDINGS MANAGEMENT INC
Resolute Holdings Management Inc is provide operating management services. The company has two operating segments and two reportable segments: Payment Card and Arculus. Payment Card generates its revenue through the production and sale of metal payment cards while Arculus generates its revenue through the production and sale of metal payment or nonpayment cards containing Arculus technology for authentication and/or digital asset cold storage and related services. The company generates maximum revenue Domestically.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.